Moreover, numerous studies have indicated that traditional Chinese medicines (TCMS) can effectively modulate NLRP3 inflammasome activity through its multi-component, multi-pathway properties, thereby improving symptoms and prognosis in CKD patients [12–14]. Here, NLRP3 is linked to chronic kidney disease.